AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇷🇼
Bevacizumab in Rwanda
3 products registered with RDA — 3 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| AVASTIN CONCENTRATE FOR SOLUTION FOR INFUSION | Rwanda FDA-HMP-MA-2044 | Roche Diagnostics GmbH and F. Hoffmann-La Roche Ltd | active | 29 Sept 2029 |
| BEVAAS 100 CONCETRATE FOR SOLUTION FOR INJECTION | Rwanda FDA-HBP-MA-005 | HETERO BIOPHARMA LIMITED | active | 17 Jul 2027 |
| BEVAAS 400 CONCETRATE FOR SOLUTION FOR INJECTION | Rwanda FDA-HBP-MA-006 | HETERO BIOPHARMA LIMITED | active | 17 Jul 2027 |
Bevacizumab — RDA Registration Details
RDA (Rwanda) has 3 registered products containing Bevacizumab, of which 3 are currently active. Data is sourced directly from the official RDA drug register and refreshed daily.
Track Bevacizumab registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.